business

AstraZeneca wins FDA approval for Enhertu in early breast cancer

Investing.com · May 18, 2026, 7:03 AM · Also reported by 4 other sources

Read full story on Investing.com → More top stories

Also covered by

STAT News STAT+: AstraZeneca picks up FDA approval for hypertension drug The Hindu Doctors at workshop stress early detection of eye cancer in children Healthline Real Housewives Star Says Breast Cancer Gave Her a ‘Different Type of Strength’ Healthline New Breast Density Treatment May Have Fewer Side Effects, Lower Cancer Risk

Aggregated and edited by the Scoop newsroom. We surface news from Investing.com alongside other reporting so you can compare coverage in one place. Editorial policy · Corrections · About Scoop

AstraZeneca wins FDA approval for Enhertu in early breast cancer

Also covered by

More in business